Oscor Inc. Launches the Adelante® Magnum Introducer for Sale in the U.S.
August 214 — Following a successful European launch, Oscor Inc. has received clearance to market the Adelante® Magnum in the U.S. The Adelante Magnum is a high performance hemostatic valve introducer for large size vascular access, specifically designed and optimized for the introduction and placement of endovascular catheters, aortic valves, and stent graft systems. The Adelante Magnum features a proprietary multilayer hydrophilic coated sheath, having a special designed distal tip portion to accept and tolerate the insertion and manipulation of large and complex devices. The Adelante Magnum SureSeal™ technology facilitates optimum hemostasis, allowing the insertion of multiple catheters and wires simultaneously with minimal blood loss. The Adelante Magnum comes readily available in multiple French sizes and sheath lengths. For more information, please email us at [email protected].
Oscor Inc., a privately held company, is an international leader in Interventional Cardiology & Interventional Radiology. Oscor is reshaping the interventional landscape with a strong emphasis on vascular access, guiding, and diagnostic technologies. Oscor core focus is providing physicians with the best tools and equipment to improve patient’s quality of life, while reducing risk, trauma, cost, procedure time, and need for extended care. With over 30 years of experience in medical field Oscor is the gold standard for both product development and quality. Oscor’s vast product offerings include steerable guiding sheaths, fixed guiding sheaths, introducers, catheters, and more. Oscor is headquartered in Palm Harbor, Florida with offices in Germany and the Dominican Republic. For more information, please visit www.oscor.com.